Perrigo Reports First Quarter 2026 Financial Results From Continuing Operations

Mitigating category headwinds with market share gains through implementation of Three‑S plan. Specialty Care segment achieved net sales and segment operating income growth, led by continued momentum in Compeed®, Opill®, and ellaOne® brands. Completed divestiture of Dermacosmetics business...